More News

15 Jan 2019 Biomunex Pharmaceuticals signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
10 Jan 2019 SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
10 Jan 2019 Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging
10 Jan 2019 Daiichi Sankyo, Mitsubishi UFJ Capital and Tokyo Institute of Technology Announce Open Innovation Research on iPS Cell-derived Insulin Producing Cells in Japan
09 Jan 2019 Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices
08 Jan 2019 Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
07 Jan 2019 bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies
07 Jan 2019 Integral Molecular Enters Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo
07 Jan 2019 3SBio and Samsung Bioepis enter biosimilar collaboration agreement
07 Jan 2019 Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
05 Jan 2019 AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
05 Jan 2019 Synaffix Announces License Agreement with Mersana Therapeutics for the Use of its GlycoConnectâ„¢ Site-Specific ADC Technology
05 Jan 2019 Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer
05 Jan 2019 Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
05 Jan 2019 Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe
05 Jan 2019 Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
05 Jan 2019 Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
03 Jan 2019 Atara Biotherapeutics Exclusively Licenses Mesothelin-Targeted CAR T Immunotherapy for Solid Tumors
03 Jan 2019 Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
03 Jan 2019 Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
03 Jan 2019 AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39
03 Jan 2019 Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics
03 Jan 2019 Kashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciences
03 Jan 2019 1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma
03 Jan 2019 Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up